NeurotechMagProGet access
News & Press

Beacon Biosignals Acquires Snap Diagnostics to Bring EEG-Enabled Home Sleep Testing to More Care Settings

GlobeNewswire10/22/2026ยท29d ago๐ŸŒ North America

Summary

Boston-based Beacon Biosignals has acquired Snap Diagnostics, a home sleep testing provider that serves patients in all 50 US states, in a deal with undisclosed terms. Snap ships tests to patients, has them scored by sleep technicians and read by specialists, and bills Medicare and commercial insurers as an accredited diagnostic testing facility. Beacon plans to pair that service with its Waveband EEG headband and AI analysis platform and offer EEG-enabled home sleep testing to primary care, telehealth, psychiatry and other specialties starting in 2027. Snap will keep its name and services for now, and Beacon says it also hopes to extend sleep diagnostics to early signs of neurodegenerative disease. The company says the deal more than doubles its patient reach.

Why it matters

It gives an EEG-based sleep device maker its own insured, nationwide testing channel, a route to market beyond selling hardware to sleep clinics. Deal terms and the reach claim come from the company, and the EEG-enabled service is still planned for 2027.

#EEG#AI/ML

Want the full NeurotechMag Pro intelligence database?

Access 800+ papers, trials, patents, funding rounds and news items โ€” updated daily.

Start free trial
Already a member? Sign in